| Record ID | marc_university_of_toronto/uoft.marc:37200130:1592 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:37200130:1592?format=raw |
LEADER: 01592cam 22003490a 4500
008 840821s1982 enk a b 1 1 eng d
013 $a8308896
020 $a0906817226 (pbk.)
039 0 $a2$b3$c3$d3$e2
046 $aDNLM$cDNLM
050 4 $aRC821$bI59 1981
060 $aW3 ME419M v.5 1982
060 $a[WI 350 I625 1981c]
090 8 $aRC 821 .I59 1981$bGERSTM$c1
111 20 $aInternational Symposium on Ranitidine$n(2nd :$d1981 :$cLondon, England)
245 14 $aThe clinical use of ranitidine :$bproceedings of the Second International Symposium on Ranitidine held at the Barbican Centre, London, UK, October 1981 /$cedited by J.J. Misiewicz, K.G. Wormsley ; coordinated by V.L. Perrin.
260 0 $aOxford [Oxfordshire] :$bMedicine Pub. Foundation,$c1982.
300 $a314 p. :$bill. --
490 1 $aThe Medicine Publishing Foundation symposium series, ISSN 0260-0242 ;$v5
504 $aIncludes bibliographical references.
650 2 $aAnti-Ulcer Agents$xtherapeutic use$xcongresses
650 2 $aFurans$xtherapeutic use$xcongresses
650 2 $aHistamine H2 Receptor Blockaders$xcongresses
650 2 $aPeptic Ulcer$xdrug therapy$xcongresses
650 0 $aPeptic ulcer$xChemotherapy$xCongresses
650 0 $aRanitidine$xCongresses
700 10 $aMisiewicz, J. J.
700 10 $aPerrin, V. L.
700 10 $aWormsley, K. G.$q(Kenneth Geoffrey)
830 0 $aMedicine Publishing Foundation symposium series.$v5
948 $a07/14/1992$b08/03/2001
949 $aRC821 .I59 1981$wLC$c1$i31761047326160$d14/3/2007$e28/2/2007$lSTACKS$mGERSTEIN$n12$q11$rY$sY$tBOOK$u26/8/1992